NorthCoast Asset Management »

Regeneron Pharmaceuticals shares owned by NorthCoast Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by NorthCoast Asset Management from 13F filings

Historical chart of NorthCoast Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by NorthCoast Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by NorthCoast Asset Management

Quarter filed Position value Share count Share price at filing
2021-09-30 $543k 898 604.68
2021-06-30 $499k 893 558.79
2021-03-31 $421k 890 473.03
2020-12-31 $432k 895 482.68
2020-09-30 $570k 1.0k 559.37
2020-06-30 $738k 1.2k 623.84
2020-03-31 $608k 1.2k 488.35

More positions owned by NorthCoast Asset Management

Ishares Tr Core S&p 500 Etf (IVV)
Apple Common (AAPL)
Ishares Tr Mbs Fixed Bdfd (MBB)
Ishares Tr Core S&p Mid-cap Etf (IJH)
Unitedhealth Group Common (UNH)
Vaneck Vectors Etf Tr Etf Hg Yld Mun (HYD)
Microsoft Corp Common (MSFT)
Ishares Msci Eurozone (EZU)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Alphabet Class A (GOOGL)
Facebook Class A (META)
Invesco Exchange Traded Fd T S&p 500 Equal Weight (RSP)
Ishares U S Etf Tr It Rt Hdg Hgyl (HYGH)
Amazon Common (AMZN)
American Express Common (AXP)

View all positions for NorthCoast Asset Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Susquehanna International
Ubs Global Asset Management Americas
Charles Schwab Investment Management

View all funds holding Regeneron Pharmaceuticals